---
figid: PMC9695187__pharmaceuticals-15-01317-g007
pmcid: PMC9695187
image_filename: pharmaceuticals-15-01317-g007.jpg
figure_link: /pmc/articles/PMC9695187/figure/pharmaceuticals-15-01317-f007/
number: Figure 7
figure_title: ''
caption: The target classes of palmatine (1), metformin (2), and glimepiride (3).
article_title: Comparative Studies of Palmatine with Metformin and Glimepiride on
  the Modulation of Insulin Dependent Signaling Pathway In Vitro, In Vivo & Ex Vivo.
citation: Okechukwu Patrick Nwabueze, et al. Pharmaceuticals (Basel). 2022 Nov;15(11):1317.
year: '2022'

doi: 10.3390/ph15111317
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- T2DM
- palmatine
- metformin
- glimepiride
- IRS1
- PI3K
- AKT2
- GLUT4

---
